Entag, Cyrus Kyle O.

HRN: 21-87-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/02/2022
09/08/2022
PO
4.2 ML
Q8
AMOEBIASIS
Waiting Final Action 
09/03/2022
CEFUROXIME 750MG (VIAL)
09/03/2022
09/10/2022
IV
195mg
Q8hours
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: